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Abstract: Supporting cell proliferation patterns were assessed in the three most posterior 
neuromasts of zebrafish larvae following treatment with 1000 μM cisplatin. Proliferation was 
upregulated 48 to 72 hours post-exposure, but survival of internal supporting cell progeny was 
low three days after treatment. This finding may account for why hair cell regeneration is 
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 The potential for hair cell regeneration therapies is currently gaining public interest and 
awareness. In a recent study conducted by Ali, Williams, Jackson, and Pau (2012), a question-
naire was distributed to members of the British Association of Otorhinolaryngologists, and 11% 
of responders reported that patients had specifically asked them about hair cell regeneration and 
stem cell therapies. Audiologists should know that the patients most likely to benefit from the 
advancement of hair cell regeneration research are those that have damage limited to the level of 
the hair cell. Deterioration of cochlear cells and structures other than hair cells, as seen in animal 
models experiencing noise-induced (Wang, Hirose, and Liberman, 2002) and age-related 
(Ohlemiller, Dahl, and Gagnon, 2010) hearing loss, would not be targeted for repair with hair 
cell regeneration therapies.  In the present study, an additional limitation of the hair cell 





I. Cisplatin Toxicity  
 
 Cis-platinum (II) diamine dichloride, commonly referred to as cisplatin, is a chemothera-
peutic agent that was first introduced in the 1970s to treat ovarian, testicular, cervical, bladder, 
lung, and head and neck tumors (reviewed in Gratton and Smyth, 2004; Yorgason, Fayad, and 
Kalinec, 2006; Rybak, 2007; Rybak, Mukherjea, Jajoo, and Ramkumar, 2009). The mechanism 
by which cisplatin appears to treat soft tissue cancers is through the creation of intrastrand cross-




dividing cells is adducted in this fashion, DNA replication is inhibited and apoptosis or 
programmed cell death is initiated if these cross-links are not repaired (e.g., by a nucleotide 
excision repair system). Similar to other platinum-based chemotherapy agents, cisplatin has 
several undesirable side effects including ototoxicity, nephrotoxicity, neurotoxicity, emesis, and 
nausea. Animal models have shown that cisplatin also damages inner ear hair cells, supporting 
cells, spiral ganglion cells, the spiral ligament, and the stria vascularis, specifically. Despite these 
known side effects, physicians continue to prescribe cisplatin to cancer patients because of its 
unparalleled effectiveness against soft tissue cancers and because neoplasms have a low 
likelihood of developing resistance to cisplatin compared to other chemotherapy drugs.    
 
II. Hair Cell Function, Death, and Regeneration 
Hair cells are mechanosensory receptor cells found within the hearing, vestibular, and 
lateral line organs of vertebrate species. When the stereocilia along the apical surfaces of hair 
cells are displaced, neural processes surrounding the hair cells generate electrical impulses that 
are transmitted to the brain (reviewed in Hudspeth, 1997). These neural inputs are used to inform 
the organism that sound waves, head movements, changes in body orientation, or surrounding 
water currents have been detected (reviewed in Matsui & Ryals, 2005 and Salvi, 2008).  
Hair cell loss contributing to hearing and/or balance disturbances can result from extreme 
environmental stress. Damaging amounts of noise, aminoglycosides, and cisplatin have all been 
shown to increase the level of reactive oxygen species (ROS) present inside hair cells and can 
initiate apoptosis when an unidentified threshold of ROS has been reached (Ou, Raible, and 
Rubel, 2007; reviewed in Gratton and Smyth, 2004; Yorgason et al., 2006; Rybak, 2007; Stone 




embryogenesis in mammalian species (reviewed in Oesterle and Stone, 2008 and Warchol, 
2011), the result of cochlear hair cell death is permanent sensory hearing loss.  
Unlike their mammalian counterparts, birds, reptiles, amphibians, and fish all maintain 
the capacity to regenerate cochlear hair cells beyond the late embryonic period. Regeneration of 
hair cells following exposure to damaging levels of noise and ototoxic drugs has also been noted 
in all four animal classes (reviewed in Oesterle and Stone, 2008; Warchol, 2011). Why hair cell 
regeneration persists in nonmammals but not mammals is unknown, but one theory proposes that 
mammals made an evolutionary tradeoff at some point in their history – the ability to regenerate 
cochlear hair cells for the complex hearing organ needed to achieve high frequency sensitivity 
(Warchol, 2011). Regardless of whether or not this theory is true, one of the main challenges to 
treating hearing loss in humans will undoubtedly be the need to regenerate cochlear hair cells 
without interfering with the intricate structure of the mammalian organ of Corti. 
Within the sensory epithelia of the auditory, vestibular, and lateral line systems, both 
sensory hair cells and nonsensory supporting cells are present. Sensory hair cell somata contact 
the luminal surface of the epithelium, and supporting cell somata are interspaced between them. 
When hair cell regeneration is not taking place, nonsensory supporting cells are in a state of 
quiescence. Their somata contact the luminal and basal surfaces of the epithelium, and their 
nuclei are located more towards the basal side. Compared to sensory hair cells in avian and fish 
species, nonsensory supporting cells are morphologically simple, exhibiting a noncomplex cyto-
skeleton and few organelles. As hair cell death occurs, it is these seemingly undifferentiated 
supporting cells that replenish the lost population of hair cells through either direct transdifferen-
tiation or mitotic proliferation (reviewed in Stone and Cotanche, 2007; Oesterle and Stone, 2008; 




During direct transdifferentiation, dying hair cells are replaced by adjacent supporting 
cells that have undergone phenotypic conversion and transformed into new hair cells. This 
mechanism, at least in theory, is capable of replacing lost hair cells so long as the endogenous 
population of supporting cells is not depleted. Surprisingly, what appears to limit the utility of 
this mechanism has less to do with the number of supporting cells remaining and more to do with 
the number of essential functions assigned to supporting cells. For instance, not only do support-
ing cells serve as precursor cells during direct transdifferentiation but they also contribute to the 
endocochlear potential through potassium (re)cycling and provide structural support to hair cells, 
spiral ganglion terminals, and the sensory epithelium as a whole. If direct transdifferentiation 
was the only method by which nonmammalian species were able to regenerate lost hair cells, 
then the sensory epithelium would effectively collapse and deteriorate whenever it experienced a 
massive hair cell lesion. For this reason, direct transdifferentiation appears to have evolved as an 
"early response" or a "quick fix" for replacing a few lost hair cells. 
When extensive hair cell damage occurs, supporting cells leave growth-arrest, reenter the 
cell cycle, and undergo mitosis. The two cells resulting from the division may then differentiate 
into a symmetrical pair of two new hair cells, a symmetrical pair of two new supporting cells, or 
an asymmetrical pair comprised of one new hair cell and one new supporting cell. Current think-
ing suggests that these three outcomes are likely balanced and highly regulated so as to ensure 
that the correct number of hair cells and supporting cells are regenerated without jeopardizing the 
important role supporting cells play in maintaining inner ear homeostasis. At present, it is 
unclear whether three different populations of supporting cells exist (i.e, a population devoted to 
direct transdifferentiation, a population devoted to mitotic proliferation, and a population 




perform all three functions based on local cell signaling. Since supporting cells serve as the 
replacement stock for dying hair cells (Williams and Holder, 2000) regardless of the hair cell 
replacement mechanism used, supporting cells can be viewed as a type of progenitor cell if not a 
true stem cell. 
 
III. The Benefits of Using a Zebrafish Model 
Neuromasts are mechanosensory organs found in fish and amphibian species. They con-
tain a cluster of centrally-located hair cells surrounded by intervening supporting cells. When 
neuromasts are organized into species-specific patterns on the bodies of fish, the result is the 
lateral line system (Ledent, 2002; Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudi-
ère, 2004; Chiu, Cunningham, Raible, Rubel, and Ou, 2008). The lateral line system is used to 
sense water disturbances in a fish’s immediate environment, and it plays an important role when 
fish are swimming in schools, socially interacting with one another, and localizing predators and 
prey (Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004).  
The embryonic posterior lateral line of zebrafish (Danio rerio) is comprised of between 
seven and eight neuromasts that extend from the head of the fish to the tip of the tail (Ledent, 
2002; Dambly-Chaudière et al., 2003; Ghysen and Dambly-Chaudière, 2004). As described in 
Ledent (2002), development of the embryonic posterior lateral line is complete by three days 
post-fertilization (dpf); however, the lateral line continues to develop as a fish matures. Starting 
between three and four dpf, new neuromasts appear interspersed between the previously deve-
loped neuromasts and posterior lateral line neuromasts begin to migrate ventrally. The three most 
posterior neuromasts, in particular, rearrange themselves with the penultimate neuromast moving 




cipation of the developing bend in a fish’s tail. Ledent stresses that postembryonic growth of the 
zebrafish lateral line is highly dependent upon a fish’ size rather than its age. When a fish 
reaches approximately 10-12 millimeters in length, its posterior lateral line neuromasts begin to 
contribute to the formation of stitches where new neuromasts appear to bud off and travel away 
from existing neuromasts in a dorsoventral fashion. 
Despite the level of postembryonic growth seen in the zebrafish lateral line, it is a 
practical model for studying hair cell death and regeneration for several reasons (Chiu et al., 
2008). First, lateral line hair cells are structurally and functionally comparable to those found 
within the mammalian inner ear despite obvious differences in cellular organization (i.e., 
neuromasts vs. the organ of Corti). Second, like inner ear hair cells, lateral line hair cells are 
vulnerable to ototoxic drugs such as aminoglycosides and cisplatin. Unlike cochlear hair cells, 
however, neuromast hair cells do no require invasive techniques to be accessed. They are 
superficially located on the body surfaces of fish. An additional benefit to working with zebra-
fish larvae is that they are optically transparent and therefore amenable to immunoflourescent 
dyes taken up by hair cells (Quigley and Parichy, 2002; Dambly-Chaudière et al., 2003). Finally, 
zebrafish larvae are an ideal laboratory specimen because they exhibit rapid development and 
high fecundity when adulthood is reached (Quigley and Parichy, 2002; Chiu et al., 2008). By 
five days old, zebrafish larvae have developed an average of 10±2.7 hair cells per neuromast 
(Genualdi, 2012), and this number doubles by ten days of age (Williams and Holder, 2000). 
 
IV. Previous Research on Hair Cell Regeneration within the Zebrafish Lateral Line  
 Several lines of research suggest that hair cell replacement within the zebrafish lateral 




differentiate into hair cells. López-Schier and Hudspeth (2006) were the first to characterize hair 
cell regeneration patterns in ET4 transgenic zebrafish following treatment with neomycin. 
According to the authors, transgenic zebrafish of the ET4 line are identical to wild-type zebrafish 
in all ways except for the expression of a green florescent protein in lateral line hair cells and in 
progenitor cells shortly before they differentiate into hair cells. Using live imaging techniques, 
López-Schier and Hudspeth monitored hair cell regeneration in the neuromasts of fourteen ET4 
trangenic zebrafish and found that, prior to their final mitosis, progenitor cells appeared in 
positions perpendicular to the neuromasts’ axes of hair cell polarization. Progenitor cells were 
thus seen in positions anterior to and posterior to neuromast hair cells when hair cells were 
regenerating along a dorsoventral axis or vice versa. Given this finding, the authors concluded 
that hair cell orientation in zebrafish larvae is partially based upon the positioning of progenitor 
cells which are, in turn, situated in the neuromast depending upon the axis of hair cell planar 
polarity. Production of the Vangl2 protein was then found to govern kinocilia and stereocilia 
arrangement atop regenerating hair cells.  
 Although López-Schier and Hudspeth did not directly investigate direct transdifferentia-
tion versus mitotic proliferation methods of hair cell replacement in the zebrafish lateral line, 
they did hypothesize that direct transdifferentiation would be unlikely to dominate over mitotic 
proliferation for two reasons. First, the time course for hair cell replacement following treatment 
with neomycin sulfate did not seem accelerated or extensive enough to suggest that supporting 
cells were transdifferentiating. Second, a single neuromast contains roughly 30 supporting cells. 
If direct transdifferentiation had been occurring to a substantial degree, this small population of 
cells would have been depleted or significantly reduced in the two day’s time it took to replace 




Additional experiments by Mackenzie and Raible (2012) have also suggested that mitotic 
regeneration is the primary mechanism by which lateral line hair cell replacement is performed 
in zebrafish. Five dpf zebrafish larvae were treated with aminoglycosides or copper (II) sulphate 
at concentration levels known to result in near complete recovery of lateral line hair cells. After 
treatment with these ototoxic compounds, larvae were incubated for two days in flubendazole, a 
drug that has limited toxicity to hair cells but has been shown to inhibit microtubule assemblage 
during chromosome segregation. After larval incubation in flubendazole, Mackenzie and Raible 
noted a significant reduction in hair cell regeneration and a significant increase in phosphory-
lated histone H3 (PH3) expression in progenitor cells. Since PH3 is expressed in mitotic cells 
transitioning from the gap 2 phase to metaphase (a stage during mitosis), the authors concluded 
that flubendazole appears to hinder hair cell regeneration by arresting cellular division—not by 
blocking direct transdifferentiation. If flubendazole had prevented precursor cells from trans-
differentiating, the authors believe they would have seen an increase in precursor cell numbers 
and not progenitor cell numbers. For this reason, the authors conclude that mitotic proliferation is 
the dominant mechanism responsible for lateral line hair cell replacement after ototoxic injury.  
Presently, two distinct supporting cell populations have been proposed to contribute to 
the regeneration of lateral line hair cells in zebrafish – an internal supporting cell population 
located in the center of zebrafish neuromasts and two to three layers of peripheral (or mantle) 
supporting cells lying along the periphery of each neuromast. During an experiment conducted 
by Ma, Rubel, and Raible (2008), five dpf zebrafish larvae were treated with neomycin and then 
incubated in the Notch inhibitor DAPT.  Following neomycin treatment and incubation in 
DAPT, internal supporting cell proliferation was found to significantly increase and peripheral 




regeneration of hair cells was then noted shortly thereafter. Based on these results, Ma et al. 
suggested that internal supporting cells undergo mitotic division and differentiation in order to 
replace lost hair cells and peripheral supporting cells only divide when the structural integrity of 
a neuromast is compromised or additional growth is required. 
Studies have shown that hair cell replacement within the zebrafish lateral line occurs as 
part of a fish’s natural development and in response to damaging insults such as tail amputation 
and ototoxic exposure (Williams and Holder, 2000; see Stone and Cotanche, 2007, for a review). 
Following treatment with aminoglycosides and limited amounts of copper (II) sulphate, for in-
stance, near complete restoration of lateral line hair cells has been observed within 24-72 hours 
of recovery (Harris et al., 2003; Ma et al., 2008; Mackenzie and Raible, 2012). Only a handful of 
studies, however, have investigated the effects of cisplatin on zebrafish lateral line hair cells.  
 
V. Justification for the Present Study 
Understanding the mechanisms underlying the initiation and maintenance of hair cell 
regeneration in animal models is important as the knowledge gained may contribute to the 
development of human hair cell replacement procedures via gene therapies, stem cell therapies, 
or possibly drug therapies that induce endogenous supporting cells to transdifferentiate into hair 
cells (Mizutari et al., 2013; reviewed in Brigande and Heller, 2009; Groves, 2010; Warchol, 
2011). While many additional factors need to be considered before one can readily assess the 
clinical utility of hair cell regeneration in humans, Matsui and Ryals (2005) and Ryals (2009) 
hypothesize that the renewal of a few fully functional and innervated hair cells within the 
cochlea would likely result in improved hearing aid benefit even if the complete restoration of 




drugs (e.g., gentamicin) may also be better able to compensate if hair cell regeneration in the 
vestibular organs can be induced.  
Given that cisplatin is toxic to hair cells, proliferating cells, and supporting cells, it seems 
plausible that cisplatin would severely limit or completely shutdown the regenerative process in 
non-mammalian species. Interestingly, Slattery and Warchol (2010) came to that conclusion in a 
study examining the capacity of chick hair cells to regenerate in the presence of cisplatin. In their 
study, cochlear and utricular organotypic cultures taken from 7-14 day post-hatch chicks were 
incubated in 0.2 to 20.0 micromolar (μM) cisplatin for 24 hours and permitted to recover for up 
to seven days. After cisplatin administration, the authors noted a dose-dependent increase in the 
amount of hair cell death and a dose-dependent decrease in the amount of cell proliferation 
observed. In addition, cisplatin-treated cultures did not show an increase in hair cell numbers 
compared to controls even after being incubated in the Notch inhibitor DAPT. Given these find-
ings, the authors concluded that cisplatin appears to have a toxic effect on both hair cells and 
supporting cells in the avian inner ear for at least seven days following cisplatin injury.  
To determine whether or not comparable effects were observed in the zebrafish lateral 
line, Genualdi (2012) treated five dpf zebrafish larvae with 1000 μM cisplatin for four hours and 
then allowed them to recover for up to 10 days. After the cisplatin exposure, neuromast hair cell 
counts were found to decrease to approximately 10-20% of those seen in undamaged controls 
and they did not fully recover. Surviving and regenerated hair cell numbers only reached 60% of 
those seen in the undamaged controls 10 days-post injury. When incubated in 50 μM DAPT, 
however, a twofold increase in the number of regenerated hair cells was noted as early as three 




cells per neuromast) that the addition of DAPT following cisplatin treatment did not appear to 
enhance the regenerative response in any meaningful way. 
Mackenzie and Raible (2012) obtained similar findings to Genualdi (2012) using a much 
lower dose of cisplatin (50 μM). Following treatment with cisplatin for 24 hours, 5 dpf zebrafish 
larvae exhibited incomplete hair cell replacement at 96 hours post-injury with the experimental 
group displaying approximately 25% fewer hair cells than the control group. In addition, the 
regenerative response following cisplatin was noted to be delayed compared to that following 
treatment with various aminoglycosides. 
 Collectively, these findings suggest that either a.) zebrafish internal and/or peripheral 
supporting cells are less susceptible to cisplatin than are chick inner ear progenitors (Genualdi, 
2012) or b.) lateral line supporting cells have some sort of robust DNA repair mechanism that is 
not found in the chick inner ear (Mackenzie and Raible, 2012). In discussing the persistence of 
hair cell regeneration in the zebrafish lateral line, however, it is important to keep in mind that 
hair cell replacement is both delayed and less robust following treatment with cisplatin than 
following treatment with aminoglycosides or copper sulphate. At present, only a few studies 
have investigated supporting cell proliferation patterns within the zebrafish lateral line after toxic 
damage. The studies that have focused primarily on the response initiated by aminoglycosides. 
No studies have assessed the resulting proliferation patterns resulting from cisplatin exposure. 
For this reason, the goal of the present study was to characterize the time course and patterning 







RESEARCH QUESTIONS AND HYPOTHESES 
 
Since antineoplastic agents are known to terminate mitotically-active cells through the 
initiation of apoptosis, the following Capstone Project sought to characterize the effects of 
cisplatin on proliferating supporting cells within the zebrafish lateral line. Specifically, we 
examined whether cisplatin was toxic to dividing inner and peripheral supporting cells as well as 
lateral line hair cells and, if so, what consequences this toxicity appeared to have on their pro-
liferation patterns compared to untreated controls. The null and alternative hypotheses for this 
project were as follows: 
• H0: Average supporting cell counts obtained for control versus experimental neuromasts 
would not be significantly different for any recovery period following treatment with 
cisplatin. 
• H1: Average supporting cell counts obtained for control versus experimental neuromasts 
would be significantly different for one or more recovery periods following treatment 
with cisplatin. 
 
MATERIALS AND METHODS 
 
I. Zebrafish Husbandry 
 Zebrafish embryos were obtained from AB wild type pairings of adult fish housed in the 
fish facility at Washington University in St. Louis. The embryos were then maintained in a tissue 
culture incubator at 28.5ºC in embryo medium (EM: 1 mM MgSO4, 0.15 mM KH2PO4, 0.04 mM 




post-fertilization (dpf), embryogensis had ended and the specimens were considered larvae 
(Ledent, 2002; Dambly-Chaudière et al., 2003). According to the guidelines set forth by the 
Institutional Animal Research Committee at Washington University in St. Louis, zebrafish larvae 
are not viewed as vertebrate animals and do not require approval for experimentation. Zebrafish 
larvae were then housed in 85 millimeter (mm) Petri dishes and fed live rotifers once per day. 
Prior to initiation of the experiments, the Petri dishes were tapped lightly to ensure that the fish 
had a normal startle response.  
 
II. Cisplatin Treatment 
Five dpf zebrafish larvae (N = 85) were incubated in a 1000 μM solution of cisplatin 
(Sigma Aldrich) for four hours at 28.5ºC. The chosen treatment protocol was selected as 
previous work by Ou et al. (2007) and Genualdi (2012) indicated that it was appropriate for kill-
ing the majority of lateral line hair cells. Age-matched controls (N = 51) were then incubated in 
cisplatin-free EM under the same conditions.  
 
III. Cell Proliferation Assay 
In order to characterize supporting cell proliferation at different points in time following 
cisplatin treatment (or lack thereof), zebrafish larvae were rinsed in fresh EM three times over 
thirty minutes and then incubated in a 5 mM solution of bromodeoxyuridine (BrdU) in EM. BrdU 
is a nucleotide analog that is incorporated into the cellular DNA of a specimen’s cells during the 
S-phase prior to mitosis. As such, it can be used to label cells preparing to undergo mitotic 





A. BrdU Pulse-Fix Protocol 
A BrdU pulse-fix protocol was used to identify all progenitor cells undergoing division 
during the final 24 hours prior to fixation. For the pulse-fix paradigm, both control and experi-
mental fish were permitted to recover for 24, 48, 72, or 96 hours in fresh EM following cisplatin 
or mock treatment. During the final 24-hour survival period, fish were then incubated in 5 mM 
BrdU in EM prior to fixation.  
Approximately twenty fish were randomly assigned to each of the eight conditions in the 
BrdU pulse-fix paradigm (cisplatin treatment x four survival periods + mock treatment x four 
survival periods = eight conditions); however, some specimens were lost during cisplatin treat-
ment or immunoprocessing. No fewer than eight and no more than nineteen fish contributed to 
the data set for each condition. 
 
B. BrdU Pulse-Chase Protocol 
A BrdU pulse-chase protocol was used to identify all progenitor daughter cells that man-
aged to survive the cisplatin treatment for up to three days. Since BrdU is incorporated into the 
cellular DNA of mitotically-active cells, all progeny arising from initial progenitor divisions con-
tain the BrdU analog and can be tracked. For the pulse-chase paradigm, experimental fish were 
treated with cisplatin for four hours; permitted to recover for 12 hours; incubated in 5 mM BrdU 
for four hours; and then permitted to recover for an additional 0, 24, 48, or 72 hours in fresh EM. 
This protocol was selected because proliferation levels were found to be at their highest approx-
imately 15 hours post-neomycin injury (Ma et al., 2008).  
Approximately 20 fish were randomly assigned to each of the four conditions in the BrdU 




no fewer than 10 and no more than 11 fish contributed to the data set for each condition. Addi-
tional fish were processed for each of the four conditions but could not be included in the final 
data sets due to time constraints. 
 
 
Figure 1. Bar graphs illustrating the main differences between the two experimental protocols. A. For the 
BrdU Pulse-Fix protocol, animals were treated with cisplatin (CPPD) for four hours, permitted to recover between 
24-96 hours, and incubated in BrdU during their final 24 hour survival period. B. For the BrdU pulse-chase protocol, 
animals were treated with CPPD for four hours, allowed to recover for 12 hours, incubated in BrdU for four hours, 
and then allowed to recover for an additional 0-72 hours. 
 
IV. Fixation and Immunohistochemistry Procedures 
All fish, regardless of the BrdU-labeling protocol employed, were sacrificed with an 
overdose of 0.02% Tricaine and fixed in 4% paraformaldehyde in phosphate buffered saline 




PBS. The specimens were then incubated in 2 normal (N) hydrochloric acid (H-Cl) for 45 min-
utes to make their fixed tissues more permeable to antibody application. After incubation in 2 N 
H-Cl, the specimens were rinsed for five minutes three times in PBS and then transferred into a 
blocking solution containing 5% normal horse serum and 95% PBS with 1% Triton X-100 deter-
gent and 1% dimethyl sulfoxide (DMSO) to further increase tissue permeability for two hours. 
As is the case with all studies employing immunohistochemistry techniques, specimens were 
blocked prior to application of the primary antibodies in order to diminish nonspecific binding of 
the primary antibodies and to improve the resulting signal-to-noise ratio. When specimens are 
blocked in this fashion, the likelihood that the primary antibody will bind to the wrong antigen 
epitopes or protein locations is reduced (Jantzie, Tanay, and Todd, 2007).  
After each specimen was blocked, the fish were incubated in PBS containing mouse anti-
BrdU primary antibodies (1:50) overnight at room temperature along with 1% Triton X-100 and 
5% normal horse serum. Anti-BrdU primary antibodies bind to BrdU antigens incorporated into 
a specimen’s DNA. Primary antibodies then serve as new epitopes for secondary antibodies con-
jugated with fluorescent molecules. One benefit to using an indirect immunohistochemistry 
procedure such as this is that multiple fluorescent secondary antibodies can bind to a single 
primary antibody and, thus, amplify the fluorescent signal observed (Jantzie et al., 2007; Carter 
and Shieh, 2010a). Additional Triton X-100 and normal horse serum were then used for the same 
reasons discussed previously. 
Following incubation in the primary antibody, the fish were rinsed for five minutes five 
times in PBS and incubated for 2 hours at room temperature in PBS containing Alexa 488-conju-
gated goat anti-mouse (1:500) secondary antibodies and 4',6-diamidino-2-phenylindole (DAPI 




tically-active nuclei to fluoresce green. The counter stain DAPI binds to the A-T regions in cell-
ular DNA and stains all cell nuclei blue. By staining all cell nuclei along the surface of the fish 
blue, the investigator was better able to identify cellular “landmarks” and, thus, more readily 
recognize where cell proliferation was taking place within the lateral line. Upon completion of 
the immunofluorescent antibody staining protocol, the zebrafish larvae were mounted on stan-
dard microscope slides and coverslipped. Care was taken to ensure that the tail surfaces of the 
specimens were lying flat and facing upwards. Positioning the fish in this manner was important 
as it provided a clear shot of the lateral line neuromasts during confocal imaging. 
 
V. Imaging 
To assess the degree of supporting cell proliferation following cisplatin treatment, a Carl 
Zeiss LSM 700 Confocal Microscope with a 20x objective lens was used to image the three most 
posterior neuromasts of each specimen. Confocal microscopy was selected for this purpose as it 
is the gold standard for imaging thick sections and small intact organisms such as zebrafish 
(Carter and Shieh, 2010b). Images were then captured using Zeiss proprietary software (ZEN) 
with the averaging parameter set to two and the acquisition speed set to seven. The gain of the 
microscope was set to the maximum value permissible before pixel saturation occurred (i.e., 
between 550-800 gain). All images were subsequently analyzed using Volocity.  
As described in Carter and Shieh (2010b), a confocal microscope works by passing a 
laser through a fluorescently stained specimen at a specified depth. The laser illuminates the 
selected plane of interest, and emitted light from the specimen is received by a detector posi-
tioned confocal to the laser. A confocal microscope essentially scans very thin sections of a 




construct 2D or 3D images of the specimen on a computer. In the present experiment, the first 
image in a Z-stack was set to a depth where the specimen’s neuromasts first became visible 
under the microscope. The last image in the Z-stack was then set to a depth inside the specimen 
where the neuromasts were no longer visible. The last image in the Z-stack captured an outline 
of the specimen's tail but did not represent the reverse side of the fish. Care was taken to ensure 
that the reverse side of the fish was not imaged as any proliferation occurring on that side would 
have contaminated the resulting 2D image.    
 
VI. Data Quantification 
Counts of mitotically-active cells were performed for the three most posterior neuromasts 
of each fish using Volocity and the XYZ image mode. Volocity’s XYZ image mode was selected 
over the Extended Focus image mode as rotating through each image of the Z-stack made it 
easier to disambiguate cases where a lot of cellular proliferation was taking place. Both single 
and dividing BrdU+ cell counts were made (Figure 2) as well as BrdU+ internal and peripheral 
supporting cells counts. Internal supporting cell counts were performed with relative ease as they 
were fairly straight forward to identify within the body of a neuromast. Peripheral supporting cell 
counts, however, proved to be more difficult as skin lesions about the neuromast appeared to 
arise from the cisplatin exposure. To help maintain consistency across neuromasts when 
counting BrdU+ internal and peripheral supporting cells, the following criteria were developed: 
1. BrdU+ cells were counted as internal supporting cells when they a.) exhibited small 
round or cylindrical nuclei and b.) were located centrally within the neuromast.  
2. BrdU+ cells were counted as peripheral supporting cells when they a.) exhibited larger 




the one to two cell layers immediately beyond the periphery of the neuromast. Large 
nebulous BrdU+ cells were never included in the peripheral cell counts unless they 




Figure 2. Cell division inside a zebrafish neuromast. Cells entering S-phase are labeled with BrdU, and 
surrounding cell nuclei are counterstained with DAPI. The long arrow with a pointed tail identifies a cell undergoing 
division at the time of fixation. The short arrow points to a single cell that has entered S-phase. Scale bar = 10 
micrometers (μm).  
 
Following peripheral and internal supporting cell counts, each neuromast was divided 
into four quadrants (anterior, ventral, posterior, and dorsal) to assess directional proliferation 
patterns. Given that existing neuromasts contribute to the formation of dorsolateral stitches 
(Ledent, 2002), the present study assessed proliferation patterns along the anteroposterior and 
dorsoventral axes. The four neuromast quadrants were created in Volocity using the line tool and 
the Alexa channel turned off. The Alexa channel was turned off so as to reduce bias when 
drawing the quadrant lines. The number of proliferating cells present in each quadrant was then 
assessed with the Alexa channel turned back on. When a BrdU+ cell fell into more than one 




is illustrated in Figure 3 below. While not initially intended for this purpose, the quadrant 
supporting cell counts provided a nice check for consistency as they were performed separately 
from the type supporting cell counts. If the investigator was consistent in making the BrdU+ 
supporting cell counts, both the quadrant and the type supporting cell counts should have 
been the same. In cases where the two counts were not equivalent, the investigator returned to 
the particular neuromast in question and performed the two counts again. Rarely did the two 







Figure 3. Creating quadrants for directional proliferation counts. In panels A and B, cells entering S-phase are 
labeled with BrdU and surrounding cell nuclei are counterstained with DAPI. A. Intersecting lines are drawn over 
the three most posterior neuromasts of each specimen using Volocity’s line tool and the BrdU channel turned off. B. 
Both channels (DAPI + BrdU) are then turned on to make cell counts for the individual quadrants. The numbers in 







VII. Data Analysis and Statistical Procedures 
Descriptive and inferential statistical analyses were conducted using Microsoft Excel. All 
resulting data are presented as means ± one standard deviation. Where appropriate, two-tailed t-
tests and one way analyses of variance (ANOVAs) were performed to assess statistical differ-
ences amongst the control and experimental data after each assigned recovery period. Multiple 
comparisons tests, such as Tukey’s test, could not be performed due to the statistical limitations 
of Excel. Differences were considered statistically significant when p < 0.05. Upon completion 
of data analysis, Excel was also used to generate representative graphs for the data. In all graphs, 




I. Results for the BrdU Pulse-Fix Experiment 
The relative amount of cell proliferation occurring in the three most posterior neuromasts 
of 5 dpf zebrafish larvae following treatment with 1000 μM cisplatin or cisplatin-free EM for 
four hours was assessed at 24, 48, 72, and 96 hours post-treatment (Figure 4). All cells under-
going DNA replication during the final 24 hours of survival were labeled by incubating the fish 
in 5 mM BrdU. Immediately following incubation in BrdU, the fish were anesthetized and fixed. 
Figure 5 displays the mean number of peripheral and internal supporting cells that had incorpor-
ated BrdU at the four assessment points. Descriptive data for all figures presented in this paper 






A. Moderate Levels of Proliferation Occur in Untreated Control Neuromasts 
As was observed in Williams and Holder (2000) and Ma et al. (2008), control neuromasts 
appeared to exhibit ongoing proliferation during the four survival periods. The reason for this 
constant turnover of cells is unknown but it has likely developed out of necessity. Unlike audi-
tory and vestibular hair cells, lateral line hair cells are directly exposed to damaging agents being 
situated on the exterior surface of a fish’s body. 
 
B. Proliferation is Transiently Upregulated in Cisplatin-Treated Neuromasts  
Overall proliferation levels declined for both the control and experimental groups during 
the first 24-96 hours after cisplatin administration. Cisplatin-treated neuromasts, however, dis-
played significantly more BrdU+ peripheral and internal supporting cells than did control neuro-
masts at the 48 and 72 hour assessment points (p < 0.05 or 0.005 for peripheral and internal 
supporting cell counts, p < 0.0005 for total supporting cell counts). This suggests that, compared 
to control animals, the number of cells entering S-phase is temporarily upregulated during the 
48-72 period following cisplatin treatment. When experimental animals were assessed another 24 
hours later, proliferation levels had returned to control levels.  
 
C. Both Supporting Cell Subpopulations Contribute Equally to the Proliferative Response 
BrdU+ internal supporting cell counts did not differ significantly from BrdU+ peripheral 
supporting cell counts at any time point in any group save for one exception. Control neuromasts 
displayed significantly more BrdU+ internal cells than peripheral cells at the 24 hour assessment 
point (p < 0.05). These findings are in stark contrast to those reported by Ma et al. (2008). 




internal supporting cell counts outnumbered BrdU+ peripheral supporting cell counts by a factor 
of approximately 2:1. Interestingly, Williams and Holder (2000) and Harris et al. (2003) noted 
the reverse trend following neomycin treatment although they did not provide exact counts for 
the two populations of cells. 
 
 
Figure 4. Supporting cell proliferation in the three most posterior neuromasts of zebrafish after treatment 
and one to four days (1D-4D) of recovery. In panels A-H, cells entering S-phase are labeled with BrdU and 
surrounding cell nuclei are counterstained with DAPI. A-D. Images depict representative neuromasts from control 
(CTL) animals following mock treatment, a recovery period, and a 24 hour BrdU pulse immediately prior to fixa-
tion. The number of additional BrdU+ cells appearing in neuromasts after the first day of recovery declines rapidly. 
E-H. Images depict representative neuromasts from cisplatin-treated (CDDP) animals following a recovery period 
and a 24 hour BrdU pulse immediately prior to fixation. The number of additional BrdU+ cells appearing in neuro-
masts after the first day of recovery declines more gradually in the cisplatin-treated fish compared to controls. Long 
arrows with pointed tails indicate sample peripheral supporting cells, and short arrows indicate sample internal 





Figure 5. Time course graph showing the mean number of internal and peripheral BrdU+ cells at each of the 
24-96 hour assessment points for the control (CRL) and cisplatin-treated (CPPD) animals in the BrdU pulse-
fix experiment. Compared to controls, a transient but significant increase in the mean number of added BrdU+ 
internal and peripheral supporting cells is seen between 48 and 72 hours after cisplatin treatment in the experi-
mental group. Mean BrdU+ internal supporting cell counts do not significantly differ from mean BrdU+ peripheral 
supporting cell counts except for in the controls at the 24 hour assessment point. Error bars represent positive 
standard deviations (N = 8-19 fish per condition, 3 neuromasts per fish). Asterisks with brackets denote significant 
differences (p < 0.05 or 0.005) between the control and experimental groups. Solitary asterisks indicate a significant 
difference (p < 0.05) between the mean internal and peripheral supporting cell counts. 
 
D. Proliferation is Homogenously Distributed within Zebrafish Neuromasts 
 Previous research has indicated that developmental growth and supporting cell prolifera-
tion could occur along either a dorsoventral or anteroposterior axis (Ledent, 2002; López-Schier 
and Hudspeth, 2006). For this reason, individual neuromasts were divided into four quadrants so 























cell counts for the dorsoventral axis were not significantly higher than BrdU+ cell counts for the 
anteroposterior axis except for in the 24 hour control group (p < 0.05).  
 
 
Figure 6. Time course graph showing the mean number of dorsoventral and anteroposterior BrdU+ cells per 
neuromast at each of the 24-96 hour assessment points for the control (CRL) and cisplatin-treated (CPPD) 
animals in the BrdU pulse-fix experiment. The mean number of additional cells entering S-phase along the dorso-
ventral axis is not significantly higher than the mean number of additional cells entering S-phase along the antero-
posterior axis except for in the controls at the 24 hour assessment point.  Error bars represent positive standard 
deviations (N = 8-19 fish per condition, 3 neuromasts per fish). The solitary asterisk denotes a significant difference 
(p < 0.05) between the mean dorsoventral and anteroposterior cell counts. 
 
II. Results for the BrdU Pulse-Chase Experiment 
Five dpf zebrafish larvae were treated with 1000 μM cisplatin for four hours and then 
incubated in 5 mM BrdU for the same period of time 12 hours post-treatment. Prior to fixation, 
fish were permitted to recover for 0, 24, 48, or 72 hours in fresh EM (Figure 7). All BrdU+ 























each zebrafish. Figure 8 displays the mean number of peripheral and internal supporting cells 
that exhibited BrdU at the four assessment points.  
 
A. Fewer BrdU+ Internal Supporting Cells Survive the Cisplatin Exposure than BrdU+ 
Peripheral Supporting Cells  
 During a BrdU pulse-chase experiment, BrdU+ cell counts are expected to increase grad-
ually over time as BrdU carrying progenitors divide. In the present experiment, the reverse trend 
was noted with both the BrdU+ internal and BrdU+ peripheral supporting cell counts declining 
between 0 and 48 hours after cisplatin. Interestingly, the mean BrdU+ counts for the peripheral 
supporting cells were significantly higher (p < 0.5 x 10-8) than those obtained for the internal 
supporting cells at every time point. This is the opposite of what was observed for the cisplatin-









Figure 7. Supporting cell proliferation in the three most posterior neuromasts of zebrafish after cisplatin 
treatment, a four-hour BrdU pulse (12 hours after cisplatin), and zero to three days (0D-3D) of recovery. 
Cells entering S-phase are labeled with BrdU and surrounding cell nuclei are counterstained with DAPI.  
A-D. Images depict representative neuromasts from cisplatin-treated (CDDP) animals in the BrdU pulse-chase 
experiment. The number of BrdU+ cells gradually declines with longer survival periods, and BrdU+ internal 
supporting cells are noticeably absent for survival periods longer than a day. Long arrows with pointed tails indicate 
sample peripheral supporting cells, and the single short arrow indicates a sample internal supporting cell. Scale bars 






Figure 8. Time course graph showing the mean number of internal and peripheral BrdU+ cells per neuro-
mast at each of the 0-24 hour assessment points for the cisplatin-treated animals in the BrdU pulse-chase 
experiment.  Mean BrdU+ peripheral supporting cell counts are significantly higher than mean BrdU+ internal 
supporting cell counts at all of the assessment points. Error bars represent positive standard deviations (N = 10-11 
fish per condition, 3 neuromasts per fish). Solitary asterisks indicate a significant difference (p < 0.5 x 10-8) between 
the mean internal and peripheral supporting cell counts. 
 
III. Results for Individual Neuromasts  
Previous research has shown that the number of hair cells regenerated following ototoxic 
injury is not uniform across lateral line neuromasts and that the number of regenerated hair cells 
is highly dependent upon the original size of the damaged neuromasts (Ma et al. 2008; Genualdi, 
2012). According to Ledent (2002), lateral line neuromasts in zebrafish larvae can vary in size 
depending upon whether they were developed early as part of the embryonic lateral line or later 
as part of the maturing lateral line. In the present experiment, differing levels of supporting cell 
proliferation were noted but not found to be significant amongst the three most posterior neuro-























chase experiment are provided for illustrative purposes (Figure 9). Since proliferating support-
ing cells have been implicated as hair cell and supporting cell progenitors (Williams and Holder, 
2000; Harris et al., 2003; Ma et al., 2008; reviewed in Stone and Contanche, 2007; Oesterle and 
Stone, 2008; Warchol, 2011; and Brignull et al., 2009), it is possible that these subtle differences 
reflect natural size variations in lateral line neuromasts as well. 
 
 
Figure 9. Time course graph showing the mean number of BrdU+ cells counted in each of the three most pos-
terior neuromasts in the BrdU pulse-chase experiment.  One way ANOVAs were performed and did not reveal 
significant differences amongst the three most posterior neuromasts at any of the assessment points. Error bars 
































I. Initial Proliferation Levels in Controls May Be Due to Ongoing Development 
Compared to control data published in other studies, the level of proliferation noted in 
our control animals is mostly consistent with previous findings. Harris et al. (2003) and Ma et al. 
(2008) assessed cell proliferation in the neuromasts of 4-5 dpf zebrafish larvae fixed after a 24 
hour survival period, and they rarely found more than two BrdU-labeled cells per neuromast. 
This number is substantially lower than the average number of BrdU+ cells we observed per 
neuromast at this time point (13.95 ± 4.64 cells per neuromast) but comparable with those 
observed at the 48 to 96 hour time points. It should be noted, however, that both Harris et al. 
(2003) and Ma et al. (2008) used a higher concentration of BrdU (10 mM) and a shorter pulse 
(one hour).  
Another explanation that may account for this apparent discrepancy in control data is that 
5-6 dpf larvae are still undergoing developmental growth during this period. In experiments con-
ducted by Ma et al. (2008), five dpf controls exhibited as much as a 20% increase in FM1-43X-
labeled, myosin VI-labeled, and HCS-1-labeled hair cells during the first 48 hours following 
mock treatment. Moderate levels of atoh1 and notch3 transcripts as well as low levels of deltaA 
transcripts were also detected up to this point in time in controls. The authors attributed these 
findings to possible hair cell addition resulting from ongoing lateral line development.  
 
II. Increased Proliferation in Cisplatin-Treated Animals is Delayed and Prolonged 
The initiation of increased supporting cell proliferation after treatment with 1000 μM cis-




12 and 21 hours post-neomycin exposure, a significant increase in BrdU+ supporting cells was 
observed in experimental neuromasts. This increase was then downregulated to near control 
levels by 24 hours post-injury (Harris et al., 2003; Ma et al., 2008). In the present study, 
cisplatin-induced proliferation was not seen until 24 hours after the reported starting point for 
neomycin. In addition, the time course for cisplatin-induced proliferation was approximately 24 
hours longer than that observed for neomycin treatment. 
 
III. Proliferation Patterns May Be Due to Extensive Cell Death in Cisplatin-Treated Neuro-
masts 
The lack of localized proliferation observed in the BrdU pulse-fix and BrdU pulse-chase 
experiments (BrdU pulse-chase data were not shown) suggests that hair cell loss occurs with 
concomitant supporting cell loss. The reason why Ma et al. (2008) recorded higher BrdU+ counts 
for the internal supporting cell population is likely due to the fact that neomycin specifically 
targets hair cells and not supporting cells. If cisplatin targets both hair cells and dividing support-
ing cells, then equivalent proliferation levels would be expected between the internal and 
peripheral supporting cell populations at some point following treatment. Internal supporting 
cells would need to divide to replace lost hair cells, and peripheral supporting cells would need 
to divide to replace lost inner supporting cells.  
In the BrdU pulse-fix experiment, the 24 hour control animals were the only ones to 
exhibit significantly more BrdU+ internal and BrdU+ dorsoventral cells. Why this was the case 
is not clear. Perhaps this difference reflects a period of active neuromast growth at 5-6 dpf that is 





IV. Many BrdU+ Internal Supporting Cells Do Not Survive Cisplatin Exposure  
The purpose of the BrdU pulse-chase experiment was to keep a running tabulation of 
approximately how many BrdU+ cells were produced after cisplatin treatment in the three most 
posterior neuromasts. Every time a BrdU+ progenitor cell divides, the BrdU analog persists in its 
daughter cells, and so BrdU+ cell counts are expected to become increasingly larger with 
progressively longer periods of survival—particularly if the progeny of those progenitor cells are 
induced to divide. Interestingly, BrdU+ cell counts did not continuously increase with each 
added recovery period of 24 hours in the present experiment. In fact, the reverse trend was 
observed between 0 and 48 hours after BrdU incubation. Since fewer BrdU+ cells were counted 
than expected with the pulse-chase protocol, this suggests that many of the daughter cells 
resulting from early mitotic divisions do not survive the cisplatin treatment even with extended 
recovery periods. This is the opposite of what Ma et al. (2008) observed when treating lateral 
line neuromasts with neomycin and indicates that cisplatin is toxic to both hair cells and 
supporting cells while neomycin is not. 
 Another interesting finding was the change in BrdU+ counts obtained for the internal 
versus peripheral supporting cell populations seen in Figures 5 and 8. In Figure 5, there were no 
significant differences between the two cell populations for BrdU incorporation in the experi-
mental animals. In Figure 8, however, the mean BrdU+ counts for the peripheral cells were sig-
nificantly higher than the mean BrdU+ counts for the internal cells at all of the survival periods. 
These findings suggest that internal supporting cell progenitors are far more susceptible to the 
effects of ciplatin than are peripheral supporting cells. Why this may be the case is unclear, but it 




after some unknown threshold of internal supporting cell death. A later time point of division 
may, therefore, permit peripheral cell nuclei to have less direct exposure to cisplatin. 
 
V. Regenerative Processes within the Zebrafish Lateral Line May Be Impaired Due to 
Limited Progenitor Survival 
As was discussed previously, cisplatin appears to impair the hair cell regenerative pro-
cesses of both the chick inner ear and the zebrafish lateral line, although the former seems to be 
far less capable of overcoming the insult than the latter. In the chick inner ear, hair cell regenera-
tion was not seen in cisplatin-treated organotypic cultures for as many as seven days post-expo-
sure (Slattery and Warchol, 2010). Hair cell regeneration in the zebrafish lateral line, however, 
was identified but found not to be complete by 10 days post-cisplatin treatment (Genualdi, 2012; 
Mackenzie and Raible, 2012). While the proliferative responses of both species are different, it is 
possible that both are impaired by the same underlying mechanism – cisplatin’s toxicity to hair 
cells, supporting cells, and proliferating cells in general.  
Results from the present study indicate that a transient increase in supporting cell prolif-
eration is seen between 48 and 72 hours post-treatment with 1000 μM cisplatin, but many of 
these putative progenitors do not appear to survive long enough to contribute to the regenerative 
process in a meaningful way. This seems particularly true for BrdU+ internal supporting cells 
which have been hypothesized to divide and give rise to new neuromast hair cells (Ma et al., 
2008). The reason why progenitor progeny fail to survive after treatment with cisplatin is ob-
scure but presumably there are lingering toxic effects from the cisplatin exposure that affect the 
internal supporting cell population similar to the hair cell population (Ou et al., 2007). At 96 




neuromasts of the zebrafish lateral line returns to control levels and hair cell replacement is still 
incomplete. Based on these observations, the delayed regenerative response observed in zebra-
fish larvae may be related to limited internal supporting cell survival. Over time, when lingering 
toxic effects from cisplatin have waned, the less susceptible peripheral supporting cells may 
gradually restore the hair cell regenerative mechanism by dividing, migrating, and differentiating 




I. Identifying the Mechanism of Internal Supporting Cell Death 
 Findings from the present study have suggested that internal supporting cells are more 
susceptible to injury by cisplatin than are peripheral supporting cells in the zebrafish lateral line. 
The method by which cisplatin effectively removes inner supporting cell progeny from zebrafish 
neuromasts is not known, but the creation of intrastrand cross-links is a likely culprit given the 
data collected. Since internal supporting cells undergo mitosis at an earlier time point after hair 
cell death than do peripheral cells, the development of DNA adducts and the inhibition of DNA 
synthesis would explain why they are comparatively more susceptible. Future research endeavors 
should explore the manner in which inner supporting cells are targeted by cisplatin (i.e., DNA 
cross-link formation versus upregulation of ROS) and how long this mechanism remains in 
effect and delays the regeneration of lateral line hair cells. Recommended analytic tools include 
adduct-specific monoclonal antibodies (used in mice in Liedert, Pluim, Schellens, and Thomale, 




Hudspeth, 2006) as they would permit one to assess the rate of DNA platination and supporting 
cell apoptosis, respectively. 
 
II. Comparing Results with Those Obtained in Mature Animals  
Zebrafish larvae are currently a popular choice for performing hair cell regeneration stu-
dies for many of the reasons discussed previously. Larvae, however, are still in the process of 
maturing. If the goal is to make hair cell regeneration therapy a viable treatment option for both 
children and adults, then studies should work to identify animal models that are easy to work 
with and that maintain a regenerative response in their adult form. Until recently, this was 
difficult in the mature zebrafish due to its opaque constitution. The casper line developed 
by White el al. (2008), however, has offered a unique opportunity. In the casper line, black 
melanophores and reflective iridophores are absent from the epidermal, dermal, and hypodermal 
layers of the fish. These mutations give the adult zebrafish a transparent appearance that makes it 
ideal for studies utilizing immunofluorescence. In addition, the casper line does not exhibit 
premature mortality compared to wild-type controls, and it maintains all of the benefits asso-
ciated with wild-type larvae. Prior to comparing the regenerative response of adults versus 
larvae, however, future research should address whether or not the casper line mutations have 










  Hair cell regeneration research in animal models is important as the knowledge gained 
may contribute to the development of human hair cell replacement therapies as well as highlight 
some of the limitations associated with these potential interventions. In the present study, five 
dpf zebrafish larvae were treated with 1000 μM cisplatin for four hours and then a.) allowed to 
recover for 24-96 hours before receiving a pulse of BrdU or b.) pulsed with BrdU 12 hours after 
cisplatin treatment and then permitted to recover for 0-72 hours. Results indicate that cisplatin 
induces both hair cell and supporting cell death as an increased and homogenous spread of 
proliferation was noted between 24-48 hours after cisplatin in the three most posterior neuro-
masts of the experimental group. While supporting cell proliferation was observed to be elevated 
during this time, long-term survival of internal supporting cell progeny was not. Considering that 
supporting cells are the progenitors of replacement hair cells, these finding may explain why hair 
cell regeneration is either absent or delayed post-cisplatin treatment. These results have 
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Supplemental Tables Containing Descriptive Data for the BrdU Pulse-Fix and Pulse-Chase 
Experiments 
 
Singlet Pair Total Singlet Pair Total
1 Day 21 5.14 0.14 5.43 7.19 0.67 8.52 5.90 8.05 13.95
2 Day 44 1.25 0.05 1.34 1.05 0.05 1.14 1.48 1.00 2.48
3 Day 47 0.40 0.00 0.40 0.51 0.13 0.77 0.57 0.60 1.17
4 Day 22 0.82 0.05 0.91 0.95 0.23 1.41 1.00 1.32 2.32
Survival Period
Table 1. Mean Control Data from the BrdU Pulse-Fix Experiment
Total SC




Singlet Pair Total Singlet Pair Total
1 Day 21 3.29 0.48 3.85 2.80 0.80 2.91 2.91 3.11 4.64
2 Day 44 1.33 0.21 1.41 1.66 0.21 1.68 1.70 1.22 2.30
3 Day 47 1.01 0.00 1.01 0.91 0.34 1.00 0.83 0.83 1.22
4 Day 22 1.59 0.21 1.93 1.59 0.43 1.53 1.23 2.01 2.83
Ant/Post
Internal SC
Survival Period Total SC
Peripheral SC




Singlet Pair Total Singlet Pair Total
1 Day 21 5.24 0.10 5.43 6.62 0.33 7.29 6.29 6.43 12.71
2 Day 25 3.36 0.08 3.52 1.92 0.16 2.24 2.92 2.84 5.76
3 Day 33 0.97 0.00 0.97 1.39 0.03 1.45 1.09 1.33 2.42
4 Day 30 0.77 0.00 0.77 1.23 0.10 1.43 1.03 1.17 2.20
Dor/VentAnt/Post Total SC
Table 3. Mean Experimental Data from the BrdU Pulse-Fix Experiment
Survival Period Neuromast N
Peripheral SC Internal SC
 
 
Singlet Pair Total Singlet Pair Total
1 Day 21 2.79 0.30 2.80 3.79 0.58 4.05 3.51 3.01 5.65
2 Day 25 2.46 0.40 2.63 1.68 0.37 1.94 1.96 2.32 3.55
3 Day 33 1.13 0.00 1.13 1.06 0.17 1.20 1.01 1.14 1.56
4 Day 30 1.22 0.00 1.22 1.22 0.40 1.48 1.00 1.34 1.86
Ant/Post Dor/Vent Total SC
Table 4. Standard Deviations for Mean Experimental Data from the BrdU Pulse-Fix Experiment







Singlet Pair Total Singlet Pair Total
1 Day 33 7.55 0.06 7.67 2.42 0.27 2.97 5.30 5.33 10.64
2 Day 33 5.58 0.03 5.64 0.91 0.03 0.97 3.42 3.18 6.61
3 Day 33 5.36 0.00 5.36 0.76 0.00 0.76 3.39 2.73 6.12
4 Day 30 6.17 0.10 6.37 1.53 0.00 1.53 4.27 3.63 7.90
Table 5. Mean Experimental Data from the BrdU Pulse-Chase Experiment
Survival Period Neuromast N




Singlet Pair Total Singlet Pair Total
1 Day 33 2.54 0.24 2.61 1.41 0.45 1.53 2.20 2.12 3.03
2 Day 33 2.89 0.17 2.86 2.26 0.17 2.26 2.19 2.11 3.89
3 Day 33 3.03 0.00 3.03 1.00 0.00 1.00 2.11 1.99 3.43
4 Day 30 2.95 0.55 3.00 2.29 0.00 2.29 2.59 2.17 4.05
Ant/PostDor/Vent Total SCSurvival Period Neuromast N
Peripheral SC Internal SC
Table 6. Standard Deviations for  Mean Experimental Data from the BrdU Pulse-Chase Experiment
 
 
